Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review

Author(s): Xin Zhao, Jinfan Tian, Zhishuai Ye, Mingyue Xu, Xiantao Song*, Rongchong Huang*

Journal Name: Current Vascular Pharmacology

Volume 19 , Issue 4 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Coronary artery spasm (CAS) plays an important role in the pathogenesis of ischemic heart disease. The clinical manifestations of CAS include variant angina, myocardial infarction and sudden death. Although endothelial dysfunction and hyperreactivity of vascular smooth muscle cells have been associated with CAS, the underlying mechanisms remain unclear. Thus, there is a long way to go to truly understand the pathogenesis of CAS to formulate effective treatments. This article discusses the pathophysiological mechanisms as well as downstream molecular pathways of CAS, with a focus on potential therapeutic targets.

Keywords: Coronary artery spasm, endothelial dysfunction, vascular smooth muscle cell hyperreactivity, therapeutic targets, ischemic heart disease, epicardial coronary artery.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 4
Year: 2021
Published on: 03 June, 2020
Page: [347 - 358]
Pages: 12
DOI: 10.2174/1570161118666200603131119
Price: $65

Article Metrics

PDF: 113